Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 770 across all filing types
Latest filing 2026-03-11 Regulatory Filings
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release issued by Mauna Kea Technologies announcing that their CLIMB study has been selected for a prestigious presentation at the ASGE Presidential Plenary Session during the Digestive Disease Week (DDW) 2026 conference. It discusses clinical research milestones and the impact of their Cellvizio technology. Since this is a corporate announcement regarding company news, research milestones, and business developments that does not fit into specific financial reporting categories like 10-K, IR, or ER, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2026-03-11 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Regulatory Filings Classification · 100% confidence The document is a standard French regulatory disclosure titled 'Information relative au nombre total de droits de vote et d'actions composant le capital social', citing Article L233-8-II of the Commercial Code and Article 223-16 of the AMF General Regulation. This type of filing is a mandatory monthly disclosure of share capital and voting rights, which falls under the category of general regulatory announcements.
2026-03-06 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Regulatory Filings Classification · 95% confidence The document is a monthly disclosure required by French regulatory authorities (AMF) regarding the total number of shares and voting rights. This type of filing is a standard regulatory requirement for listed companies in France to inform the market of changes in capital structure. Since it does not fit into specific categories like 'Share Issue' (which would describe a specific transaction) or 'Major Shareholding' (which would describe a specific investor's position), it falls under the general regulatory filing category.
2026-03-06 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from Mauna Kea Technologies announcing the receipt of regulatory approvals for the commercialization of its Cellvizio product in Switzerland and the UK. It also mentions a new commercial order. This type of corporate announcement regarding business operations, market expansion, and regulatory milestones that does not fit into specific financial reporting or governance categories is best classified as a general regulatory filing or corporate announcement.
2026-02-23 French
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release issued by Mauna Kea Technologies announcing regulatory clearances for its Cellvizio platform in Switzerland and the UK, as well as a new commercial order. It does not constitute a formal financial report, audit, or proxy statement. As it is a general corporate announcement regarding business operations and regulatory milestones that does not fit into more specific categories like M&A or dividend announcements, it is classified as a general regulatory filing.
2026-02-23 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from Mauna Kea Technologies announcing the receipt of CE MDR certification for its Cellvizio product. It is a corporate announcement regarding a regulatory milestone and business development, not a financial report, audit, or shareholder meeting material. As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory announcement category.
2026-02-10 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.